Home Overview Press Room Blog Publications For Students about us

‘Gene drive’ moratorium shot down at UN biodiversity meeting

by Ewen CallawayNature
December 21st, 2016

The game, Jenga, is set up with themed animals and plants on each pieces. A human hand attempts to remove one piece from the connected collection.

Untitled Document

Freeze on genetic technology would have been a disaster, say scientists, but activists plan to renew the fight.

World governments at a United Nations biodiversity meeting this week rejected calls for a global moratorium on gene drives, a technology that can rapidly spread modified genes through populations and could be used to engineer entire species. But environmental activists’ appeals for a freeze on gene-drive field trials, and on some lab research, are likely to resurface in the future.

“I’m very relieved,” says Andrea Crisanti, a molecular parasitologist at Imperial College London, who is part of an effort that seeks to use gene drives to control malaria. He and others worry that a moratorium would make research on the technology more difficult, scare away funders and prevent field tests. “It would have been a disaster for developing the technology,” he says.  But the calls for a ban, discussed at the meeting of the UN Convention on Biodiversity (CBD) in Cancún, Mexico, on 4–17 December, are not going to go away, he says. “Those who are opposed to this technology will be more organized next time.”

The idea of a moratorium found support among some countries. But a final agreement released on 16 December merely urged caution in field-testing the products of synthetic biology, including gene drives, while supporting better risk-assessment of the products’ potential effects.

“It’s a way of governments saying ‘we need to know more about these technologies before making these decisions. At the same time, we are worried they may have impacts on biological diversity,’” says Calestous Juma, a former executive secretary of the CBD and an expert on science and technology policy at Harvard University in Cambridge, Massachusetts.

Continue reading full article on Nature News...

Image via Flickr

This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of biotechnology and public policy issues. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.copyright.gov/title17/92chap1.html#107. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.


home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760